The Gamma Knife market

The Gamma Knife market is witnessing significant growth due to the increasing prevalence of cancer and obesity and the growing aging population.

The Gamma Knife Market Size, Share and Growth

The Gamma Knife Market was worth $229.55million in 2018 and is expected to reach $349.8 million by 2023, with a CAGR of 8.79% from 2018 to 2023.

To know more, read @ https://www.marketdataforecast.com/market-reports/gamma-knife-market

The Gamma Knife Market Overview:

Radiotherapy is a procedure that involves accurately delivering high doses of radiation to tumors and other relevant anatomical targets. Radiosurgery with Gamma Knife is an essential form of radiotherapy. It is mainly used to treat brain tumors, arteriovenous malformations, trigeminal neuralgia, acoustic neuroma, and pituitary tumors. In surgery with Gamma Knife, the specialized team concentrates about 200 small radiation beams in a tumor or other specific cells. These packages deliver high doses of radiation to targeted tumor cells with refined precision. This effectively means that the surrounding healthy tissues are exposed to minimal or no radiation.

The Gamma Knife Market Drivers and Restraints:

Globally, the Gamma Knife market is witnessing significant growth due to the increasing prevalence of cancer and obesity and the growing aging population. Besides, rising number of initiatives undertaken by various government associations and the advanced features of Gamma Knife systems are also driving the growth of the market. However, stringent regulatory requirements and prolonged approval time for Gamma Knife systems and high cost of implementation and shortage of skilled workforce inhibit the growth of the market.